Oncology │ NSCLC │ EGFR Plus
Empowering treatment decisions in NSCLC
EGFR and its role in the world’s deadliest cancer
Did you know that lung cancer is the leading cause of cancer mortality, worldwide (1)? In Europe, it’s the second most diagnosed cancer in men and the third in women, with over 477,500 new cases in 2020 (1). Non-small cell lung cancer (NSCLC) makes up about 85% of those cases (2).
Contact an expert
Discover how EGFR testing can help you and your patients.
The therascreen EGFR Plus RGQ PCR Kit is intended for in vitro diagnostic use.